Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2026-02-20 @ 6:25 PM
Study NCT ID:
NCT03689894
Status:
TERMINATED
Last Update Posted:
2023-11-28
First Post:
2018-09-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ibrutinib Plus Rituximab for cGVHD Following Allo-SCT
Sponsor:
Dartmouth-Hitchcock Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
D17120
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None